tiprankstipranks
Trending News
More News >
Cytori Cell Research Institute, Inc. (JP:3750)
:3750
Japanese Market

Cytori Cell Research Institute, Inc. (3750) Ratios

Compare
0 Followers

Cytori Cell Research Institute, Inc. Ratios

JP:3750's free cash flow for Q3 2024 was ¥-1.83. For the 2024 fiscal year, JP:3750's free cash flow was decreased by ¥ and operating cash flow was ¥-8.17. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
1.58 1.18 3.04 8.53 7.98
Quick Ratio
1.48 1.08 1.39 1.69 1.37
Cash Ratio
1.01 0.96 0.86 1.46 1.23
Solvency Ratio
-0.15 -0.06 0.02 -0.05 0.04
Operating Cash Flow Ratio
0.00 -0.03 -0.19 -0.11 0.65
Short-Term Operating Cash Flow Coverage
0.00 -0.04 -0.26 -0.16 0.97
Net Current Asset Value
¥ -2.17B¥ -10.05B¥ -9.26B¥ -5.11B¥ -5.17B
Leverage Ratios
Debt-to-Assets Ratio
0.54 0.60 0.58 0.57 0.57
Debt-to-Equity Ratio
1.32 3.21 2.50 2.41 2.30
Debt-to-Capital Ratio
0.57 0.76 0.71 0.71 0.70
Long-Term Debt-to-Capital Ratio
0.53 0.74 0.70 0.69 0.68
Financial Leverage Ratio
2.42 5.31 4.31 4.21 4.06
Debt Service Coverage Ratio
0.65 -0.58 0.42 -0.63 0.07
Interest Coverage Ratio
-11.74 -6.15 -4.96 -8.66 -2.24
Debt to Market Cap
0.45 0.84 0.91 0.72 1.38
Interest Debt Per Share
306.33 967.27 1.06K 1.05K 1.31K
Net Debt to EBITDA
-2.44 -10.47 24.12 -28.50 180.60
Profitability Margins
Gross Profit Margin
49.14%59.17%64.33%54.77%64.07%
EBIT Margin
-390.86%-48.34%2.09%-41.04%31.93%
EBITDA Margin
-343.75%-32.89%26.12%-18.86%3.64%
Operating Profit Margin
-333.63%-37.04%-34.62%-52.70%-10.93%
Pretax Profit Margin
-471.50%-54.37%-4.89%-47.13%27.03%
Net Profit Margin
-22.82%-49.42%-5.81%-59.92%27.03%
Continuous Operations Profit Margin
-22.73%-49.41%-5.77%-55.86%26.95%
Net Income Per EBT
4.84%90.90%118.82%127.15%100.00%
EBT Per EBIT
141.32%146.79%14.13%89.42%-247.29%
Return on Assets (ROA)
-1.23%-7.52%-0.49%-5.57%2.06%
Return on Equity (ROE)
-2.49%-39.96%-2.09%-23.47%8.37%
Return on Capital Employed (ROCE)
-19.79%-6.15%-3.08%-5.16%-0.88%
Return on Invested Capital (ROIC)
-0.89%-5.22%-3.47%-5.90%-2.05%
Return on Tangible Assets
-1.23%-7.91%-0.51%-5.89%2.18%
Earnings Yield
-1.02%-10.48%-0.76%-7.05%5.01%
Efficiency Ratios
Receivables Turnover
37.69 18.96 11.38 16.97 0.00
Payables Turnover
0.00 -39.74 0.00 0.00 0.00
Inventory Turnover
3.07 7.54 0.29 0.12 0.08
Fixed Asset Turnover
0.06 0.18 0.11 0.19 0.15
Asset Turnover
0.05 0.15 0.08 0.09 0.08
Working Capital Turnover Ratio
0.75 1.91 0.35 0.25 0.00
Cash Conversion Cycle
128.55 76.88 1.29K 2.94K 4.62K
Days of Sales Outstanding
9.69 19.26 32.07 21.51 0.00
Days of Inventory Outstanding
118.87 48.44 1.26K 2.92K 4.62K
Days of Payables Outstanding
0.00 -9.18 0.00 0.00 0.00
Operating Cycle
128.55 67.69 1.29K 2.94K 4.62K
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 -4.43 -21.27 -10.13 79.11
Free Cash Flow Per Share
0.00 -22.18 -41.66 -12.08 79.11
CapEx Per Share
0.00 17.75 20.39 1.95 0.00
Free Cash Flow to Operating Cash Flow
0.00 5.01 1.96 1.19 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 -0.25 -1.04 -1.00 3.96
Capital Expenditure Coverage Ratio
0.00 -0.25 -1.04 -5.19 0.00
Operating Cash Flow Coverage Ratio
0.00 >-0.01 -0.02 >-0.01 0.06
Operating Cash Flow to Sales Ratio
0.00 -0.02 -0.14 -0.06 0.45
Free Cash Flow Yield
0.00%-1.96%-3.59%-0.84%8.34%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-97.87 -9.54 -131.82 -14.18 19.95
Price-to-Sales (P/S) Ratio
22.34 4.72 7.66 8.50 5.39
Price-to-Book (P/B) Ratio
2.92 3.81 2.76 3.33 1.67
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -51.08 -27.82 -119.30 11.98
Price-to-Operating Cash Flow Ratio
0.00 -255.99 -54.50 -142.27 11.98
Price-to-Earnings Growth (PEG) Ratio
0.69 >-0.01 1.44 0.05 0.00
Price-to-Fair Value
2.92 3.81 2.76 3.33 1.67
Enterprise Value Multiple
-8.94 -24.81 53.46 -73.54 328.59
Enterprise Value
8.11B 17.50B 18.65B 19.26B 14.13B
EV to EBITDA
-8.94 -24.81 53.46 -73.54 328.59
EV to Sales
30.74 8.16 13.96 13.87 11.97
EV to Free Cash Flow
0.00 -88.37 -50.70 -194.81 26.61
EV to Operating Cash Flow
0.00 -442.84 -99.32 -232.31 26.61
Tangible Book Value Per Share
225.80 220.40 336.81 335.74 442.77
Shareholders’ Equity Per Share
226.02 297.10 420.47 433.15 567.91
Tax and Other Ratios
Effective Tax Rate
0.95 0.09 -0.18 -0.19 <0.01
Revenue Per Share
29.55 240.21 151.26 169.63 175.80
Net Income Per Share
-6.74 -118.71 -8.79 -101.64 47.52
Tax Burden
0.05 0.91 1.19 1.27 1.00
Interest Burden
1.21 1.12 -2.35 1.15 0.85
Research & Development to Revenue
2.01 0.07 0.02 0.00 0.00
SG&A to Revenue
0.00 0.07 0.10 0.00 0.13
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.15 0.00
Income Quality
0.00 0.03 2.87 0.13 1.66
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis